Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast | 15 | 2024 | 1968 | 1.880 |
Why?
|
Breast Neoplasms | 31 | 2024 | 20763 | 1.450 |
Why?
|
Breast Diseases | 4 | 2021 | 443 | 1.350 |
Why?
|
Body Fluids | 6 | 2013 | 318 | 1.160 |
Why?
|
Labor, Obstetric | 5 | 2016 | 317 | 1.130 |
Why?
|
Testosterone | 4 | 2024 | 2439 | 0.960 |
Why?
|
Premature Birth | 6 | 2020 | 1725 | 0.870 |
Why?
|
Obstetric Labor, Premature | 2 | 2014 | 272 | 0.850 |
Why?
|
Cervix Uteri | 5 | 2013 | 583 | 0.810 |
Why?
|
Vagina | 6 | 2013 | 806 | 0.810 |
Why?
|
Infectious Mononucleosis | 1 | 2022 | 135 | 0.780 |
Why?
|
Nipples | 1 | 2023 | 220 | 0.760 |
Why?
|
Mammary Glands, Human | 1 | 2021 | 203 | 0.680 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2013 | 299 | 0.680 |
Why?
|
Labor Onset | 3 | 2010 | 17 | 0.530 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 597 | 0.520 |
Why?
|
Abortion, Threatened | 1 | 2014 | 4 | 0.490 |
Why?
|
Retinal Dehydrogenase | 2 | 2024 | 78 | 0.470 |
Why?
|
Mammography | 2 | 2024 | 2426 | 0.470 |
Why?
|
Term Birth | 5 | 2014 | 135 | 0.450 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 85 | 0.430 |
Why?
|
Androgens | 1 | 2020 | 1276 | 0.430 |
Why?
|
Blood Cells | 1 | 2014 | 299 | 0.410 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 70 | 0.390 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2011 | 59 | 0.390 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2013 | 134 | 0.390 |
Why?
|
Serum Albumin | 1 | 2014 | 672 | 0.390 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 145 | 0.380 |
Why?
|
Cystatin A | 1 | 2010 | 6 | 0.380 |
Why?
|
Body Mass Index | 5 | 2024 | 12657 | 0.380 |
Why?
|
Cervix Mucus | 1 | 2010 | 16 | 0.380 |
Why?
|
Cysteine Proteases | 1 | 2010 | 21 | 0.370 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2011 | 128 | 0.360 |
Why?
|
Postmenopause | 2 | 2019 | 2462 | 0.360 |
Why?
|
Diterpenes | 1 | 2011 | 163 | 0.350 |
Why?
|
Capsaicin | 1 | 2011 | 226 | 0.350 |
Why?
|
Gene Expression | 4 | 2020 | 7590 | 0.350 |
Why?
|
Substance P | 1 | 2011 | 332 | 0.350 |
Why?
|
Cathepsins | 1 | 2010 | 244 | 0.340 |
Why?
|
Menarche | 2 | 2024 | 527 | 0.340 |
Why?
|
TRPV Cation Channels | 1 | 2011 | 238 | 0.330 |
Why?
|
Health Surveys | 1 | 2018 | 3962 | 0.320 |
Why?
|
Pregnancy | 15 | 2020 | 29297 | 0.310 |
Why?
|
Female | 53 | 2024 | 382450 | 0.310 |
Why?
|
Nurses | 3 | 2022 | 2441 | 0.300 |
Why?
|
Interleukin-1beta | 1 | 2013 | 974 | 0.290 |
Why?
|
Receptors, Estrogen | 6 | 2022 | 2168 | 0.280 |
Why?
|
Proteomics | 4 | 2024 | 3709 | 0.260 |
Why?
|
Adult | 31 | 2024 | 215192 | 0.260 |
Why?
|
Epidemiology | 2 | 2019 | 274 | 0.260 |
Why?
|
Vaginal Smears | 1 | 2008 | 497 | 0.250 |
Why?
|
Databases, Genetic | 4 | 2020 | 1732 | 0.250 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3578 | 0.250 |
Why?
|
Pathology, Molecular | 2 | 2019 | 332 | 0.240 |
Why?
|
Urinary Bladder | 1 | 2011 | 1168 | 0.240 |
Why?
|
Carcinoma, Renal Cell | 1 | 2019 | 3173 | 0.240 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9320 | 0.230 |
Why?
|
Sex Reassignment Procedures | 1 | 2024 | 62 | 0.230 |
Why?
|
Keratin-7 | 1 | 2023 | 57 | 0.220 |
Why?
|
Humans | 55 | 2024 | 746630 | 0.210 |
Why?
|
Receptors, Androgen | 2 | 2019 | 1066 | 0.210 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4272 | 0.210 |
Why?
|
Spinal Cord | 1 | 2011 | 1774 | 0.210 |
Why?
|
Parity | 2 | 2021 | 914 | 0.210 |
Why?
|
Antioxidants | 1 | 2010 | 1643 | 0.210 |
Why?
|
Trans-Activators | 3 | 2020 | 2850 | 0.200 |
Why?
|
Middle Aged | 22 | 2024 | 214618 | 0.200 |
Why?
|
Analysis of Variance | 3 | 2021 | 6226 | 0.190 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 915 | 0.190 |
Why?
|
Gestational Age | 4 | 2020 | 3520 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3789 | 0.190 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 635 | 0.180 |
Why?
|
Risk Factors | 14 | 2024 | 72447 | 0.180 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 72 | 0.180 |
Why?
|
Reproductive History | 1 | 2021 | 210 | 0.180 |
Why?
|
Hyperplasia | 1 | 2023 | 1154 | 0.170 |
Why?
|
Neck | 1 | 2024 | 703 | 0.170 |
Why?
|
Radon | 1 | 2020 | 83 | 0.170 |
Why?
|
Erythrocyte Membrane | 1 | 2020 | 441 | 0.160 |
Why?
|
Elasticity | 1 | 2021 | 653 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8902 | 0.160 |
Why?
|
Alcohol Drinking | 3 | 2023 | 3962 | 0.150 |
Why?
|
Body Size | 1 | 2021 | 459 | 0.150 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 2853 | 0.150 |
Why?
|
Sex Reassignment Surgery | 1 | 2020 | 151 | 0.150 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2018 | 124 | 0.150 |
Why?
|
RNA, Messenger | 3 | 2020 | 12767 | 0.140 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15010 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1060 | 0.140 |
Why?
|
Automation | 1 | 2019 | 581 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 355 | 0.140 |
Why?
|
Mammary Glands, Animal | 1 | 2018 | 264 | 0.140 |
Why?
|
Risk Assessment | 5 | 2021 | 23464 | 0.140 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1065 | 0.140 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11865 | 0.140 |
Why?
|
MicroRNAs | 2 | 2024 | 3748 | 0.140 |
Why?
|
Lymphatic Metastasis | 1 | 2024 | 2919 | 0.130 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2018 | 411 | 0.130 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2019 | 462 | 0.130 |
Why?
|
Western Australia | 1 | 2014 | 38 | 0.120 |
Why?
|
Proteins | 1 | 2010 | 6007 | 0.120 |
Why?
|
Genomics | 3 | 2022 | 5695 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2021 | 21693 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6460 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1556 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1531 | 0.120 |
Why?
|
Prognosis | 8 | 2024 | 29079 | 0.120 |
Why?
|
Adiposity | 2 | 2021 | 1825 | 0.120 |
Why?
|
Aldehyde Dehydrogenase | 2 | 2024 | 146 | 0.110 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3585 | 0.110 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 930 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19819 | 0.110 |
Why?
|
Menopause | 1 | 2021 | 1615 | 0.110 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3409 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2024 | 3449 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1777 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1616 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1758 | 0.100 |
Why?
|
Unsafe Sex | 1 | 2013 | 211 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1858 | 0.100 |
Why?
|
Estradiol | 1 | 2018 | 1945 | 0.100 |
Why?
|
Demography | 1 | 2016 | 1630 | 0.100 |
Why?
|
Time Factors | 5 | 2014 | 39622 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2000 | 0.090 |
Why?
|
Proteome | 2 | 2013 | 1813 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2299 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1511 | 0.090 |
Why?
|
Biopsy | 4 | 2024 | 6734 | 0.090 |
Why?
|
Fibronectins | 1 | 2014 | 720 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2020 | 3787 | 0.090 |
Why?
|
Computational Biology | 2 | 2020 | 3489 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23154 | 0.090 |
Why?
|
Amniotic Fluid | 1 | 2011 | 377 | 0.080 |
Why?
|
Thioredoxins | 1 | 2010 | 204 | 0.080 |
Why?
|
Sacrum | 1 | 2011 | 276 | 0.080 |
Why?
|
Risk | 1 | 2021 | 9522 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2846 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 926 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2020 | 4315 | 0.080 |
Why?
|
Phthalazines | 2 | 2022 | 373 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9193 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2022 | 2830 | 0.080 |
Why?
|
Infant, Small for Gestational Age | 1 | 2011 | 434 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3306 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 586 | 0.080 |
Why?
|
Cohort Studies | 4 | 2024 | 40534 | 0.080 |
Why?
|
Anthropometry | 2 | 2024 | 1338 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2176 | 0.070 |
Why?
|
Labor, Induced | 1 | 2008 | 144 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13170 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2011 | 1857 | 0.070 |
Why?
|
Protease Inhibitors | 1 | 2010 | 753 | 0.070 |
Why?
|
Aged | 6 | 2024 | 164383 | 0.070 |
Why?
|
Mitosis | 2 | 2024 | 1191 | 0.070 |
Why?
|
Air Pollution | 1 | 2020 | 2288 | 0.070 |
Why?
|
Vitamin D | 1 | 2020 | 3240 | 0.070 |
Why?
|
Air Pollutants | 1 | 2020 | 2806 | 0.070 |
Why?
|
Models, Genetic | 1 | 2016 | 3425 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4399 | 0.060 |
Why?
|
Maternal Age | 1 | 2008 | 798 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2020 | 1109 | 0.060 |
Why?
|
Oxidation-Reduction | 1 | 2010 | 2187 | 0.060 |
Why?
|
Male | 7 | 2024 | 351420 | 0.060 |
Why?
|
Retrospective Studies | 5 | 2024 | 78313 | 0.060 |
Why?
|
Phenotype | 2 | 2022 | 16261 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2020 | 25759 | 0.060 |
Why?
|
Giant Cells | 1 | 2023 | 183 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2470 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12217 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4856 | 0.050 |
Why?
|
Birth Weight | 1 | 2011 | 2060 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12021 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2869 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 562 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14124 | 0.050 |
Why?
|
Age Factors | 3 | 2024 | 18157 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 330 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 86278 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 2011 | 1819 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2024 | 494 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 421 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7786 | 0.050 |
Why?
|
Stem Cells | 2 | 2024 | 3513 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8356 | 0.050 |
Why?
|
Mastectomy | 2 | 2019 | 1816 | 0.040 |
Why?
|
Niacinamide | 1 | 2022 | 414 | 0.040 |
Why?
|
Alberta | 1 | 2020 | 60 | 0.040 |
Why?
|
Regression Analysis | 1 | 2010 | 6334 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 57163 | 0.040 |
Why?
|
Obesity | 2 | 2021 | 12728 | 0.040 |
Why?
|
Cesarean Section | 1 | 2008 | 1366 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2021 | 551 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2010 | 3033 | 0.040 |
Why?
|
Child | 3 | 2022 | 78492 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13810 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 10 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 29627 | 0.040 |
Why?
|
Premenopause | 1 | 2023 | 1033 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10750 | 0.040 |
Why?
|
NAD | 1 | 2022 | 595 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2019 | 151 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 56 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 883 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 629 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 579 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 613 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2022 | 1108 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1609 | 0.030 |
Why?
|
Morpholines | 1 | 2019 | 574 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7236 | 0.030 |
Why?
|
Pathology | 1 | 2019 | 263 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 560 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1301 | 0.030 |
Why?
|
Cell Cycle | 1 | 2024 | 2922 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2019 | 509 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2022 | 2075 | 0.030 |
Why?
|
Rats | 1 | 2011 | 23696 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 748 | 0.030 |
Why?
|
Tamoxifen | 1 | 2019 | 957 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16667 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 572 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2023 | 2887 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2008 | 14543 | 0.030 |
Why?
|
Phosphorylation | 1 | 2024 | 8294 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2047 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 163 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2019 | 1586 | 0.030 |
Why?
|
Chromatin | 1 | 2023 | 2896 | 0.020 |
Why?
|
Neoplasms | 2 | 2019 | 21715 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 53253 | 0.020 |
Why?
|
Cell Division | 1 | 2018 | 4440 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 25184 | 0.020 |
Why?
|
Animals | 4 | 2024 | 166558 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3478 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2467 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3695 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6102 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3262 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2472 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4516 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2019 | 2964 | 0.020 |
Why?
|
Particulate Matter | 1 | 2020 | 2518 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6789 | 0.020 |
Why?
|
Specimen Handling | 1 | 2013 | 695 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 280 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2456 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5664 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4823 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5761 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 2011 | 886 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2008 | 403 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5166 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2018 | 3667 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9513 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12280 | 0.020 |
Why?
|
Mice | 2 | 2024 | 80251 | 0.020 |
Why?
|
Diet | 1 | 2022 | 7888 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9213 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10311 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11584 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 38771 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 41390 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 13503 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 17689 | 0.010 |
Why?
|